Pharmaceutical
Prove the real-world value of your therapy - continuously, in the real conditions of care.
Demonstrating clinical value is no longer enough. Aenduo supports you in turning every day chronic care into continuous, structured real-world evidence - the measurable proof of therapeutic value that access, reimbursement and patient programmes now depend on.
Pharmaceutical
The evidence gap you're facing.
Bringing a therapy to market is no longer the finish line — proving its value in the real world is. Between marketing authorisation and reimbursement lies a gap that payers and Health Technology Assessment (HTA) bodies now fill with one demand: measurable, real-world proof of therapeutic and economic value
Information trapped in silos.
Real-world data is generated every day butscattered across heterogeneous sources and systems that werenever designed to share it, making it hard to aggregate and analyse.
Value must be proven beyond the trial.
Marketing authorisation no longer guarantees reimbursement: payers and HTA bodies increasingly require real-world evidence of value, and bridging that gap is a recognised challenge across European countries.
Real-world evidence is hard to generate — and to get accepted.
Turning routine care data into evidence that HTA bodies accept demands a level of quality, consistency and methodological rigour that real-world settings rarely provide by default.
Adherence gaps carry a real cost.
Medication non-adherence remains a major, well-documented burden on clinical outcomes and health-system costs across Europe, while end-of-study surveys capture recall, not behaviour.
Real conditions, complex patients.
Demonstrating that results generalise across real populations with comorbidities remains an open challenge for value demonstration and HTA.
How we bring it to life
Real-world data from everyday care
Evidence collected continuously in the real setting of care — replacing the end-of-study survey with a live signal.
Structured evidence for access & value
Adherence, outcomes and usage returned as structured, exportable evidence to support access dossiers and reimbursement negotiations.
One connected, compliant data foundation
Interoperability that breaks the silos, with security managed at platform level — GDPR and NIS2 compliant, data hosted in Europe or, for sovereign deployments, in-country and on-premise — so patient data never crosses a border.
Patient engagement, beyond the prescription
Patient-reported out comes, reminders and tele-support that keep patients engaged and their data flowing throughout the pathway.
Related products
The difference Aenduo makes for you
Evidence generate dat scale, in real European care settings:
Managed patients
Healthcare organizations
biometric parameters
Implementation
How we work alongside you.
A single point of contact runs the implementation, and support continues after go-live — so the project keeps its momentum and your teams stay supported at every step.
The answers you’re looking for
Let’s talk about the evidence you need to generate.
A conversation with a specialist, our experience at your disposal: we bring what we’ve learned across more than 200 health organizations, you bring your access and evidence goals.
Some images on this website may have been generated or edited using artificial intelligence tools and are intended for illustrative purposes only.